These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28879901)

  • 21. Heterogeneity and excitability of BRAFV600E-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss.
    Cases-Cunillera S; van Loo KMJ; Pitsch J; Quatraccioni A; Sivalingam S; Salomoni P; Borger V; Dietrich D; Schoch S; Becker AJ
    Neuro Oncol; 2022 May; 24(5):741-754. PubMed ID: 34865163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
    Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
    Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI characteristics predict BRAF V600E status in gangliogliomas and pleomorphic xanthoastrocytomas and provide survival prognostication.
    Jiang B; Zheng Y; She D; Xing Z; Cao D
    Acta Radiol; 2024 Jan; 65(1):33-40. PubMed ID: 37401109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.
    Wang Y; Wang L; Blümcke I; Zhang W; Fu Y; Shan Y; Piao Y; Zhao G
    Brain Pathol; 2022 Jan; 32(1):e13011. PubMed ID: 34355449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma.
    Koelsche C; Sahm F; Paulus W; Mittelbronn M; Giangaspero F; Antonelli M; Meyer J; Lasitschka F; von Deimling A; Reuss D
    Neuropathol Appl Neurobiol; 2014 Apr; 40(3):337-44. PubMed ID: 23822828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report.
    Cicuendez M; Martinez-Saez E; Martinez-Ricarte F; Asanza EC; Sahuquillo J
    J Neurosurg Pediatr; 2016 Jul; 18(1):53-7. PubMed ID: 27015517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors.
    Boer K; Troost D; Timmermans W; van Rijen PC; Spliet WG; Aronica E
    Brain Pathol; 2010 Jan; 20(1):234-44. PubMed ID: 19371356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
    Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual inhibition of BRAF and mTOR in
    Sen S; Tanaka R; Khatua S; Zaky W; Janku F; Penas-Prado M; Weathers SP; Behrang A; Roszik J; Subbiah V
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases.
    Gessi M; Dörner E; Dreschmann V; Antonelli M; Waha A; Giangaspero F; Gnekow A; Pietsch T
    Hum Pathol; 2016 Mar; 49():107-13. PubMed ID: 26826417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atypical ganglioglioma with BRAF V600E mutation: a case report and review of the literature].
    Martinez-Ricarte F; Martinez-Saez E; Cicuendez M; Cordero E; Auger C; Toledo M; Radoi A; Sahuquillo J
    Rev Neurol; 2016 May; 62(10):455-9. PubMed ID: 27149188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas.
    Chen X; Pan C; Zhang P; Xu C; Sun Y; Yu H; Wu Y; Geng Y; Zuo P; Wu Z; Zhang J; Zhang L
    J Clin Neurosci; 2017 Dec; 46():50-57. PubMed ID: 28986151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
    Faustino A; Couto JP; Pópulo H; Rocha AS; Pardal F; Cameselle-Teijeiro JM; Lopes JM; Sobrinho-Simões M; Soares P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1139-49. PubMed ID: 22549934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases.
    Aisner DL; Newell KL; Pollack AG; Kleinschmidt-Demasters BK; Steinberg GK; Smyth LT; Vogel H
    Clin Neuropathol; 2014; 33(2):112-21. PubMed ID: 24321241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis.
    Xing H; Song Y; Zhang Z; Koch PD
    J Mol Neurosci; 2021 Sep; 71(9):1815-1824. PubMed ID: 33791912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of BRAF status in glial and glioneuronal tumors: A systematic review.
    Sugiura Y; Nagaishi M
    J Clin Neurosci; 2019 Aug; 66():196-201. PubMed ID: 31147232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Dabrafenib for three children with brainstem BRAF
    Philippe L; Maria K; Tariq A; Sofia M; Christine SM; Jean-Pierre F; Dudley RW; Sébastien P; Nada J; Valérie L
    J Neurooncol; 2019 Oct; 145(1):135-141. PubMed ID: 31502039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation.
    Greer A; Foreman NK; Donson A; Davies KD; Kleinschmidt-DeMasters BK
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27860162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors.
    Koh HY; Kim SH; Jang J; Kim H; Han S; Lim JS; Son G; Choi J; Park BO; Heo WD; Han J; Lee HJ; Lee D; Kang HC; Shong M; Paik SB; Kim DS; Lee JH
    Nat Med; 2018 Nov; 24(11):1662-1668. PubMed ID: 30224756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.